Haemonetics (HAE) Enterprise Value (2016 - 2025)
Haemonetics (HAE) has 17 years of Enterprise Value data on record, last reported at -$363.4 million in Q4 2025.
- For Q4 2025, Enterprise Value fell 13.25% year-over-year to -$363.4 million; the TTM value through Dec 2025 reached -$363.4 million, down 13.25%, while the annual FY2025 figure was -$306.8 million, 71.57% down from the prior year.
- Enterprise Value reached -$363.4 million in Q4 2025 per HAE's latest filing, down from -$296.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$173.5 million in Q3 2021 and bottomed at -$363.4 million in Q4 2025.
- Average Enterprise Value over 5 years is -$262.6 million, with a median of -$272.0 million recorded in 2022.
- Peak YoY movement for Enterprise Value: surged 37.15% in 2024, then plummeted 71.57% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$192.4 million in 2021, then dropped by 16.41% to -$224.0 million in 2022, then rose by 13.4% to -$194.0 million in 2023, then crashed by 65.4% to -$320.8 million in 2024, then fell by 13.25% to -$363.4 million in 2025.
- Per Business Quant database, its latest 3 readings for Enterprise Value were -$363.4 million in Q4 2025, -$296.4 million in Q3 2025, and -$292.9 million in Q2 2025.